SCHEMBL8113441

SCHEMBL8113441

C=CCOC(=O)[C@H](CC(C)C)[C@H](O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 2/20 0.34
RNPEP Q9H4A4 1/20 0.33
SLC7A5 Q01650 1/20 0.33
CYP3A4 P08684 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
LAP3 P28838 2/20 0.31
LTA4H P09960 1/20 0.31
ANPEP P15144 1/20 0.31
MAPT P10636 1/20 0.30
CACNA1B Q00975 1/20 0.30
APBA1 Q02410 1/20 0.30
ALDH1A1 P00352 1/20 0.30
SLC1A3 P43003 1/20 0.30
SLC1A2 P43004 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8113439 1.00 TDP1 (0.41) TDP1TSHRRNPEPSLC7A5CYP3A4
SCHEMBL6942402 0.85 TDP1 (0.40) TDP1TSHRCYP3A4TAS1R3TAS1R1
SCHEMBL6942403 0.85 TDP1 (0.40) TDP1TSHRCYP3A4TAS1R3TAS1R1
SCHEMBL15443387 0.82 TDP1 (0.45) TDP1TSHRCYP3A4TAS1R3TAS1R1
SCHEMBL6804648 0.82 TDP1 (0.40) TDP1TSHRRNPEPSLC7A5CYP3A4
SCHEMBL6368830 0.79 TDP1 (0.41) TDP1TSHRCYP3A4MAPTCACNA1B
SCHEMBL7611792 0.77 TDP1 (0.46) TDP1TSHRRNPEPSLC7A5CYP3A4
SCHEMBL167950 0.76 TSHR (0.43) TDP1TSHRCYP3A4MAPTCACNA1B
SCHEMBL2363000 0.74 TSHR (0.42) TDP1TSHRCYP3A4MAPTCACNA1B
Lactic Acid SCHEMBL27586439 0.74 TP53 (0.46) TDP1TSHRCYP3A4MAPTCACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-04-19 EP disclosed
WO-1999001428-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-01-14 WO disclosed